Related Experiment Videos
Comment on "Impaired respiratory and body temperature control upon acute serotonergic neuron inhibition"
Stefan Löffler1, Jochen Körber, Udo Nubbemeyer
1Department of Psychiatry and Psychotherapy, Clinic Offenbach, Teaching Hospital of Goethe University, D-63069 Offenbach, Germany. stefloeffler@t-online.de
Abstract:
Ray et al. (Reports, 29 July 2011, p. 637) assume that clozapine-N4-oxide (CNO) represents a "biologically inert synthetic ligand" that selectively activates the M4 muscarinic receptor-based DREADD (designer receptor exclusively activated by a designer drug). In contrast, due to the redox cycling of CNO with clozapine and to their cell membrane permeability, CNO is biologically active and its conversion products are capable of undermining DREADD effects.
Related Concept Videos
Increased Body Temperature
Drugs Affecting Neurotransmitter Release or Uptake
Drugs Affecting Neurotransmitter Synthesis
Excitatory and Inhibitory Effects of Neurotransmitters
Decreased Body Temperature
Homeostatic Imbalances in Body Temperature